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The pandemic novel influenza A (H1N1) infection was considered widespread in Brazil on July 16, 2009. Since then, 46,810 cases 
of acute respiratory syndrome have been reported in Brazil, most of them concentrated in São Paulo. Through September 16, we 
have confirmed 9,249 cases of novel influenza A H1N1in Brazil, including 699 deaths. The mortality rate observed in Brazil is 
0.47/100,000 inhabitants and varies according to region. In this period, São Paulo registered 3733 cases (40.3% of the total) of 
novel influenza A (H1N1) infection and 327 deaths, reflecting a mortality rate of 0.79/100,000 inhabitants.
The Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC) is a reference center for H1N1 cases in 
São Paulo. During the winter of 2009, 472 patients in this hospital were diagnosed with H1N1 infection; of these, 210 were admit-
ted, and 16 died. To control this pandemic and to provide adequate care for these patients, the Hospital das Clínicas implemented 
“bundles” including prevention strategies, an epidemiologic surveillance service, availability of fast diagnosis, antiviral treatment 
and training of staff. 
The purpose of this manuscript is to describe the epidemiologic features of novel human influenza A (H1N1) infection in the 
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo during the winter period of the 2009 pandemic.
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INTRODUCTION
In April 2009, the first cases of human infection with a 
novel influenza A (H1N1) virus were reported in the United 
States and Mexico.1,2 The novel H1N1 virus possesses 
distinct molecular properties of human, avian, and swine 1026
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influenza and is a highly transmissible and mutable virus 
known as the swine origin influenza virus (S-OIV).3,4 
As of September 13, 2009, novel H1N1 has caused 
296,471 virologically confirmed human cases, resulting 
in at least 3,486 deaths in countries worldwide.  5 Since 
April of this year, human health agencies worldwide have 
been attempting to deal with this new pandemic disease, 
establishing prevention strategies, improving diagnostic 
methods and adopting therapeutic measures. 6,7,8
Pandemic novel influenza A (H1N1) infection was 
considered widespread in Brazil on July 16.  9 Since the 
first reported case of H1N1 infection, Brazil’s Ministry of 
Health, as suggested by the World Health Organization, has 
maintained continuous epidemiologic vigilance of cases of 
acute respiratory syndrome (ARS). This strategy of vigilance 
considers any persons with flu syndrome as potential cases 
of influenza A (H1N1), designating as potential cases all 
individuals who present with acute respiratory syndrome 
with cough, dyspnea, and fever. 9
The Hospital das Clínicas da Faculdade de Medicina 
da Universidade de São Paulo (HC) is the largest tertiary 
health care facility in Brazil and is a reference center for 
H1N1 cases in Sao Paulo. To help control the pandemic, the 
Hospital das Clínicas Council created the “Cabinet Crisis”, a 
group of healthcare professionals who continuously evaluate 
“bundles”, groups of interventions and advertisements for 
control of S-OIV infection, to obtain better outcomes in the 
management of this disease. Two of the main responsibilities 
of this committee are to provide continuous epidemiologic 
vigilance and to acquire expertise in performing adequate 
diagnosis and treatment of patients.
This manuscript describes the epidemiologic features of 
novel human influenza A (H1N1) infection in the Hospital 
das Clínicas da Faculdade de Medicina da Universidade de 
São Paulo during the winter period of the 2009 pandemic.
2. EPIDEMIOLOGY IN BRAZIL
Currently, 46,810 cases of acute respiratory syndrome 
(ARS) have been reported in Brazil. 9 Of these, 9,249 (20%) 
patients presented infection with novel influenza A (H1N1) 
virus. Seasonal influenza A infection was confirmed in 1,152 
(2.5%) patients.  9 All states in Brazil except for Sergipe 
reported cases. H1N1 occurrence is concentrated in the 
states of Paraná, Sao Paulo and Rio Grande do Sul. A peak 
of incidence was observed in August, with a later decrease 
(Figure 1).
Sao Paulo is the most populated state in Brazil and 
presents the majority of reported H1N1 cases. As of 
September 12, 2009, 13,069 cases of acute respiratory 
syndrome, of which 3,733 were due to novel influenza A 
(H1N1) infection, were registered in São Paulo. São Paulo 
state registered 40.3% (3,733 of 9,249) of the confirmed 
cases in Brazil, with the majority identified in the city. 
Compared to Paraná and Rio Grande do Sul, São Paulo 
presents the lowest mortality rate - (0.79/100,000 inhabitants 
versus 1.36/100,000 and 2.08/100,000 inhabitants, 
respectively). 9,10 
The mortality rate by age and gender for H1N1 cases 
in Sao Paulo state is shown in Figure 2. Females and 
individuals 20-39 years of age present the highest risk of 
mortality. These data are similar to those reported in Brazil 
and worldwide. In Brazil, the mortality rate is 0.47/100,000 
inhabitants and varies according to region. Argentina, 
Paraguay, Australia and Chile present higher rates of 
mortality (1.27, 0.81, 0.80 and 0.77/100,000 inhabitants, 
respectively).9 
In Brazil, among the reported cases, H1N1-infected 
individuals tend to be young, with a median age of 26 
years. Most patients are 15-49 years of age. The observed 
age distribution is unusual and differs from that seen with 
seasonal influenza, being skewed toward younger age 
groups. With respect to gender distribution, 57.5% of the 
confirmed cases of novel virus influenza A (H1N1) occur 
in women. 9,10
Following the first reported case on July 16, the Ministry 
of Health initiated a nationwide global action plan with the 
goal of offering information on prevention and providing 
rapid diagnosis and adequate treatment. 11 
Figure 1 - Distribution of cases of acute respiratory syndrome in Brazil 
according to epidemiologic week from week 31 to 36, 2009 (data obtained 
from Ministry of Health of Brazil)9
Figure 2 - Mortality rate by sex and age group (per 100,000 inhabitants) - 
São Paulo state - Brazil, as of 5th September1027
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3. EPIDEMIOLOGIC FEATURES OF H1N1 CASES 
SEEN IN THE HOSPITAL DAS CLÍNICAS
The Hospital das Clínicas da Faculdade de Medicina 
da Universidade de São Paulo (HC) is the largest tertiary 
health care hospital in Brazil, with 1953 regular beds, 351 
ICU beds, and 63,631 patients admitted per year. The HC is 
a complex of 5 medical institutes (Instituto Central, Instituto 
de Ortopedia, Instituto de Radiologia, Instituto da Criança, 
Instituto de Psiquiatria) and other associated hospitals 
(Hospital de Suzano e de Cotoxó) and is a reference center 
for H1N1 cases in São Paulo. Two other hospitals are linked 
to the HC: the Hospital do Cancer do Estado de São Paulo 
and Hospital Emílio Ribas. Both participated in the use of 
HC “bundles” aimed at controlling the pandemic. (“Bundles” 
are groups of interventions and advertisements being used in 
order to obtain better outcomes in the management of this 
disease).
From June 2009 through September 2009, the Hospital 
das Clínicas da Faculdade de Medicina da Universidade de 
Sao Paulo registered 1500 cases of novel human influenza 
A (H1N1) infection and confirmed 472 cases (Table 1). Of 
these patients, 210 (46%) were admitted to regular ward or 
intensive care units. The remaining patients were diagnosed 
at the emergency department (216 - 45%) or at ambulatory 
care centers (46 – 9%) and received home treatment after 
being provided with adequate information (Table 1). 
Of 122 confirmed cases of infection with seasonal 
influenza A, 53 patients (43%) were hospitalized. During 
this period, a high incidence of hospital admission due to 
respiratory symptoms (700 patients) occurred; 210 of the 
admitted patients were confirmed to have S-OIV infection 
(Figure 3). Analysis of the distribution of cases by week 
revealed that a peak of incidence occurred in August and 
that the number of cases progressively decreased after week 
32 (Figure 3). 
At the beginning of the pandemic, the cases reported 
by the Hospital das Clínicas most frequently involved mild 
forms of the disease; most of the attending was done at the 
emergency room, and the patients were discharged. After 
July, we observed an increase in hospital admissions due to 
a higher frequency of more severe cases and an increased 
number occurring in high risk populations (Figure 4).
More than half of our patients were between 0 and 29 
years of age and were female (Table 2); this distribution 
is similar to the age and gender distribution reported in 
other series. 12 Perhaps due to the status of this hospital as 
a reference center for H1N1 treatment, most of the patients 
attended in the HC (85.5%) presented at least one co-
morbidity. Immunosuppression, chronic respiratory disease, 
and cardiovascular disease were the most frequent risk 
factors present in these patients, occurring in 15.6%, 14.3% 
Table 1 - Cases reported by final diagnosis and local of attendance - Hospital das Clinicas - FMUSP – June 16 to September 
18, 2009
               
Diagnosis Emergency room  Hospitaliza-tion Ambulatory TOTAL
nº % nº % nº % nº %
Novel Influenza A H1N1 216 46 210 45 46 9 472 31.5
Influenza A 65 53 53 43 4 3.2 122 8.1
Other diagnoses 344 38 433 48 125 14 902 60.1
Ongoing investigation 0 0 4 0.6 0 0 4 0.4
Total  625 100 700 100 175 100 1500 100
Figure 3 - Distribution of confirmed cases of seasonal Influenza A and 
Influenza A (H1N1) admitted in the HC-FMUSP - 06/16 to 09/18 - 2009
Figure 4 - Distribution of reportable cases in the HC-FMUSP according to 
the local of attending - June 16 to September 181028
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and 12.3% of the patients, respectively (Table 2). These 
groups of risk are similar to related in the literature.13,14,15 
We reported 35 cases in pregnant women, including 2 
deaths. One of the pregnant women who died presented 
a very severe form of the disease characterized by acute 
respiratory distress syndrome, renal failure and hepatic 
insufficiency. The severity of H1N1 infection in pregnancy 
has been reported by other authors and may be due to the 
frequent occurrence if some degree of immunosupression 
in pregnant women. 16 In Brazil, 856 pregnant women were 
affected, and 91 died. 9
 Previous data on S-OIV infection in humans have shown 
that the majority of affected patients are healthy individuals 
who present an influenza-like illness, with fever, cough and 
myalgia occurring in nearly 100% of cases.17 Cough, fever, 
rhinorrhoea, dyspnea and myalgia were the symptoms most 
frequently encountered in the cases from HC (Table 2). 
Of 472 confirmed cases of novel H1N1 infection seen at 
the Hospital das Clínicas, 210 were admitted due to severity 
of symptoms or due to the patient’s co-morbidities. Of these, 
176 cases (83.8%) were discharged recovered, 13 are still 
hospitalized (6.2%), 5 were transferred to other institutions 
(2.4%), and 16 (7.6%) died (Table 3). All the deaths, with 
the exception of one, were related to a severe form of lung 
disease characterized by acute respiratory distress syndrome, 
refractory hypoxemia, shock and ultimately multiple organ 
failure.
 As previously stated, the Hospital das Clínicas is a 
complex of institutes and associated hospitals. As a result 
of a measure adopted by the “Crisis Cabinet” to control 
the pandemic, the attending and human resources devoted 
to control and treatment of H1N1 infection, including a 
specialized structure of intensive care units and regular 
wards, were concentrated in the Instituto Central. Most of 
the cases (86 patients – 41%) were admitted to the Instituto 
Central and presented a median length of stay of 9.4 days 
(Table 4). The Instituto da Criança admitted 64 cases (30%), 
with 5.7 days median length of stay. The other institutes and 
hospitals presented lower numbers (Table 4). The deaths 
were registered in Instituto Central (8), Instituto do Câncer 
(5) and in the Instituto do Coração (3). 
In the last 30 days, the HC epidemiologic surveillance 
service describes a significant decrease in the number of 
cases of novel human H1N1 infection. The Ministry of 
Health in Brazil registers a similar control of the pandemic, 
with just a few cases reported since week 35 (30 August to 
05 September). In the Hospital das Clínicas, the strategy 
implemented by the “Crisis Cabinet” included:
1.  Periodic meetings among healthcare professionals from 
all institutions, including directors, professors, epidemi-
ologists, infectologists, and intensive care physicians, to 
discuss new data and information about the disease.
2.  Continuous local epidemiologic surveillance to collect 
and analyze data for assessment of the impact of the 
virus and identification of groups at an increased risk of 
complications.
Table 2 -  Clinical and epidemiologic aspects of 472 con-
firmed cases of novel Influenza A (H1N1) - Hospital das 
Clinicas FMUSP - June 16 to September 18, 2009
   
Variable Novel Influenza A H1N1
nº %
Gender                         
Female 262 55.5
Age
0 – 9 107 22.7
10 – 19 77 16.3
20 - 29  98 20.8
30 – 39 60 12.7
40 – 49 50 10.6
50 – 59 50 10.6
>=60  30 6.4
Total 472 100.0
Median age 25
(<1 to 88 
years)
Pre-existing conditions
Immunosuppression 72 15.3
Chronic respiratory disease 69 14.6
Chronic cardiovascular disease 58 12.3
Heath care professional  40 8.5
Pregnancy 35 7.4
Chronic metabolic disorder 22 4.7
Cancer  14 3.0
Smoke 15 3.2
Transplants 10 2.1
Without comorbidity 73 15.5
Presenting manifestations
Cough 398 84.3
Fever 378 80.1
Rhinorrhoea 229 48.5
Dyspnea 198 41.9
Myalgia 186 39.4
Sore throat 123 26.1
Arthralgia 61 12.9
Diarrhea 37 7.8
Conjunctivitis 34 7.2
Headache 31 6.61029
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3.  Provision of information about novel influenza A infec-
tion, symptoms, diagnosis, and prevention to all profes-
sionals and patients.
4.  Availability of real-time RT-PCR for (H1N1) virus in 
admitted patients.
5.  Reduction in the number of daily visits of families to the 
hospital.
6.  Implementation of hygienic measures including alcohol-
based hand cleaner, gloves, and masks.
7.  Internet published recommendations on the management 
of infection (www.hcnet.usp.br)
8.  Specific units for the care of patients with suspected or 
confirmed S-OIV infection including emergency room 
attending, regular ward and specialized intensive care 
units.
9.  Guidance for staff and coworkers to limit contact with 
other people when symptoms are present.
10. Risk group-specialized protocols for the treatment of 
pregnant women, children, immunocompromised pa-
tients, and those with chronic diseases.
11. Immediate availability of antiviral therapy.
The diagnostic approach adopted in the HC includes 
the full-time availability of a real-time transcriptase reverse 
polymerase chain reaction (RT-PCR) for novel influenza 
A (H1N1).18,19 Samples for laboratory tests are obtained 
from the deep nasal passages (nasal swab), nasopharynx 
(nasopharyngeal swab), or bronchial aspirate, if available. As 
recommended, the test is performed in the following cases: 20
a) patients who require hospitalization;
b) patients with risk factors for severe forms of disease;
c) patients in an individualized protocol, according to clini-
cal judgment.
In the Hospital das Clínicas, antiviral therapy is directed 
to specific groups:
1.  All hospitalized patients with confirmed, probable, or 
suspected novel influenza (H1N1).
a.  Patients who are at a higher risk for complications: 
-  Individuals with underlying chronic diseases: 
asthma, chronic obstructive airway disease, diabe-
Table 3 - Hospitalized cases of acute respiratory syndrome and the clinical endpoint after final diagnostic - Hospital das 
Clinicas - FMUSP - June, 16 to September, 18 - 2009
Type of discharge Novel Influenza A Influenza A Others diagnostics Total**
nº % nº % nº % nº %
Discharged 176 83.8 44 83.0 299 69.1 519 74.6
Death* 16 7.6 2 3.8 59 13.6 77 11.1
Extern transfer 5 2.4 6 5.7 8 1.8 16 2.3
Hospitalized 13 6.2 4 7.5 67 15.5 84 12.1
Total** 210 100.0 53 100.0 433 100.0 696 100.0
*1 death of confirmed case died of cause not related to (H1N1) infection; **4 cases waiting for final laboratory diagnosis.
Table 4 - Number of hospitalized patients with novel Influenza H1N1 and length of stay according to the Institute or associ-
ated Hospital in the HC-FMUSP- June 16, to September, 18 - 2009
Hospital Final Diagnostic
Novel Influenza A Influenza A Others diagnostics Total*
nº LOS nº LOS nº LOS nº LOS
Instituto Central 86 9.4 25 7.4 148 7.2 259 7.9
Instituto da Criança 64 5.7 13 16.5 113 6.9 190 7.1
Instituto do Coração 31 8.7 6 8.5 75 8.8 112 8.7
Instituto do Câncer 9 4.1 5 3.6 51 7.3 65 6.6
Hospital de Cotoxó 13 10.6 1 0.0 28 6.3 42 7.5
Instituto de Ortopedia e Traumatologia 1 0.0 0 - 2 10.5 3 7.0
Instituto da Criança - ITACI 5 8.6 3 12.0 8 6.6 16 8.3
Instituto de Psiquiatria 1 1.0 0 - 6 9.3 7 8.1
Hospital de suzano 0 - 0 - 2 1.0 2 1.0
Total** 210 7.4 53 9.5 433 6.0 696 7.7
**4 cases waiting for final laboratory diagnosis. LOS = lenght of stay in days1030
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tes, immunocompromise, chronic cardiovascular 
disease, chronic renal failure, epilepsy, obesity, 
and cancer. 
-  Pregnant women.
-  Children under two years of age.
-  Individuals > 65 years of age.
We hypothesize that an association of factors contributed 
to the recent reduction in the number of cases seen in the 
HC. These factors likely include seasonal variation (the 
end of winter), the presence of continuous epidemiologic 
monitoring and the provision of adequate information on 
prevention to the population. 
We believe that the centered care associated with 
acquired expertise in H1N1 diagnosis and the adequate 
treatment that we provide to patients with the disease are 
responsible for the good results observed in the Hospital 
das Clínicas. Worldwide, after an initial decrease in the 
number of infections, it was observed that, during week 37 
(September 13-19, 2009), influenza activity increased in the 
United States of America and in Europe. 5,21
 In the Hospital das Clínicas, we wish to maintain all 
the adopted measures described herein, with the ongoing 
objective of obtaining better outcomes in the management of 
novel influenza A (H1N1) infection. Through accumulating 
experience and continuing study of individual groups of 
patients, we hope to continuously contribute information 
regarding the epidemiology, pathogenesis and clinical 
aspects of this pandemic.
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